• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION Back to Search Results
Model Number 2P36-25
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Eye Injury (1845); Chemical Exposure (2570)
Event Type  Injury  
Manufacturer Narrative
A review of complaints found no trends or similar issues for the complaint issue.Manufacturing documentation for the reagent lot did not identify any issues associated with the complaint issue.Labeling was reviewed and found to adequately address the biological and chemical safety hazards that may exist.The architect hiv ag/ab package insert states that this product contains human sourced and/or potentially infectious components and should be considered potentially infectious.It is recommended that these reagents and human specimens be handled in accordance with the osha standard on bloodborne pathogens.In addition, the safety data sheet (sds) for the architect hiv ag/ab states that if the material comes in contact with the eye to rinse cautiously with water for several minutes.If eye irritation persists, get medical advice/attention.Wear safety glasses or other protective eyewear.If splash potential exists, wear full face shield or goggles.The sds documents that there is no irritant effect to eyes by the reagent.Since the user was not wearing eye protection as required per the safety instructions as outlined in the architect hiv ag/ab package insert and the safety data sheet (sds) use error contributed to the incident.Based on our investigation no product deficiency was identified for the architect (b)(6) reagent, list number 02p36.Section a patient information: no specific patient/user information was provided.
 
Event Description
The customer reported an employee who was splashed in the eyes with architect (b)(6) combo controls.The user was disposing of used controls when the contents of the control material splashed into the eyes.The user was not wearing protective eyewear at the time of exposure (a use error).The user is undergoing exposure treatment with prophylaxis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HIV AG/AB COMBO REAGENT KIT
Type of Device
TEST, HIV DETECTION
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key10837156
MDR Text Key216412952
Report Number3002809144-2020-01110
Device Sequence Number1
Product Code MZF
UDI-Device Identifier00380740003890
UDI-Public00380740003890
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/26/2021
Device Model Number2P36-25
Device Catalogue Number02P36-25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/23/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/26/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-